Detalhe da pesquisa
1.
Polypill with or without Aspirin in Persons without Cardiovascular Disease.
N Engl J Med
; 384(3): 216-228, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186492
2.
Diet, cardiovascular disease, and mortality in 80 countries.
Eur Heart J
; 44(28): 2560-2579, 2023 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414411
3.
A hybrid automated event adjudication system for clinical trials.
Clin Trials
; 20(2): 166-175, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734212
4.
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.
Lancet
; 398(10306): 1133-1146, 2021 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469765
5.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996147
6.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984808
7.
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
Eur Heart J
; 42(31): 2995-3007, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963372
8.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197271
9.
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.
Stroke
; 52(8): 2494-2501, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985364
10.
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.
Lancet
; 395(10226): 785-794, 2020 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31492501
11.
Modifiable risk factors, cardiovascular disease, and mortality in 155â722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
Lancet
; 395(10226): 795-808, 2020 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31492503
12.
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
Stroke
; 51(10): 2901-2909, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32951537
13.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet
; 394(10193): 121-130, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189511
14.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet
; 394(10193): 131-138, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189509
15.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844192
16.
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Gastroenterology
; 157(2): 403-412.e5, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054846
17.
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Gastroenterology
; 157(3): 682-691.e2, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152740
18.
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Cardiovasc Diabetol
; 19(1): 199, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239067
19.
Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.
Lancet
; 392(10146): 496-506, 2018 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129465
20.
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Lancet
; 391(10117): 205-218, 2018 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132879